| Year |
Citation |
Score |
| 2024 |
Lu T, Ma R, Mansour AG, Bustillos C, Li Z, Li Z, Ma S, Teng KY, Chen H, Zhang J, Villalona-Calero MA, Caligiuri MA, Yu J. Preclinical Evaluation of Off-The-Shelf PD-L1+ Human Natural Killer Cells Secreting IL15 to Treat Non-Small Cell Lung Cancer. Cancer Immunology Research. PMID 38572955 DOI: 10.1158/2326-6066.CIR-23-0324 |
0.322 |
|
| 2024 |
Li Z, Ma R, Tang H, Guo J, Shah Z, Zhang J, Liu N, Cao S, Marcucci G, Artis D, Caligiuri MA, Yu J. Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death. Cell. PMID 38211590 DOI: 10.1016/j.cell.2023.12.015 |
0.365 |
|
| 2023 |
Sayegh M, Ma S, Yu J. Application of natural killer immunotherapy in blood cancers and solid tumors. Current Opinion in Oncology. 35: 446-452. PMID 37551952 DOI: 10.1097/CCO.0000000000000968 |
0.367 |
|
| 2023 |
Ma S, Caligiuri MA, Yu J. Harnessing Natural Killer Cells for Lung Cancer Therapy. Cancer Research. PMID 37531223 DOI: 10.1158/0008-5472.CAN-23-1097 |
0.334 |
|
| 2023 |
Mansour AG, Teng KY, Li Z, Zhu Z, Chen H, Tian L, Ali A, Zhang J, Lu T, Ma S, Lin CM, Caligiuri MA, Yu J. Off-the-Shelf CAR-Engineered Natural Killer Cells Targeting FLT3 Enhance Killing of Acute Myeloid Leukemia. Blood Advances. PMID 37379267 DOI: 10.1182/bloodadvances.2022007405 |
0.339 |
|
| 2023 |
Kumar A, Taghi Khani A, Duault C, Aramburo S, Sanchez Ortiz A, Lee SJ, Chan A, McDonald T, Huang M, Lacayo NJ, Sakamoto KM, Yu J, Hurtz C, Carroll M, Tasian SK, et al. Intrinsic suppression of type I interferon production underlies the therapeutic efficacy of IL-15-producing natural killer cells in B-cell acute lymphoblastic leukemia. Journal For Immunotherapy of Cancer. 11. PMID 37217248 DOI: 10.1136/jitc-2022-006649 |
0.33 |
|
| 2023 |
Li X, Yan X, Wang Y, Kaur B, Han H, Yu J. The Notch signaling pathway: a potential target for cancer immunotherapy. Journal of Hematology & Oncology. 16: 45. PMID 37131214 DOI: 10.1186/s13045-023-01439-z |
0.528 |
|
| 2023 |
Yu J, Caligiuri MA. Viral- and tumor-reactive natural killer cells. Seminars in Immunology. 67: 101749. PMID 36965383 DOI: 10.1016/j.smim.2023.101749 |
0.446 |
|
| 2023 |
Lu H, Liu Z, Deng X, Chen S, Zhou R, Zhao R, Parandaman R, Thind A, Henley J, Tian L, Yu J, Comai L, Feng P, Yuan W. Potent NKT cell ligands overcome SARS-CoV-2 immune evasion to mitigate viral pathogenesis in mouse models. Plos Pathogens. 19: e1011240. PMID 36961850 DOI: 10.1371/journal.ppat.1011240 |
0.361 |
|
| 2023 |
Hong B, Sahu U, Mullarkey MP, Hong E, Pei G, Yan Y, Otani Y, Banasavadi-Siddegowda Y, Fan H, Zhao Z, Yu J, Caligiuri MA, Kaur B. PKR induces TGF-β and limits oncolytic immune therapy. Journal For Immunotherapy of Cancer. 11. PMID 36796878 DOI: 10.1136/jitc-2022-006164 |
0.53 |
|
| 2023 |
Ma S, Sun B, Duan S, Han J, Barr T, Zhang J, Bissonnette MB, Kortylewski M, He C, Chen J, Caligiuri MA, Yu J. YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8 T cells. Nature Immunology. PMID 36658237 DOI: 10.1038/s41590-022-01398-6 |
0.377 |
|
| 2022 |
Ma R, Li Z, Chiocca EA, Caligiuri MA, Yu J. The emerging field of oncolytic virus-based cancer immunotherapy. Trends in Cancer. PMID 36402738 DOI: 10.1016/j.trecan.2022.10.003 |
0.448 |
|
| 2022 |
Tian L, Xu B, Chen Y, Li Z, Wang J, Zhang J, Ma R, Cao S, Hu W, Chiocca EA, Kaur B, Caligiuri MA, Yu J. Specific targeting of glioblastoma with an oncolytic virus expressing a cetuximab-CCL5 fusion protein via innate and adaptive immunity. Nature Cancer. PMID 36357700 DOI: 10.1038/s43018-022-00448-0 |
0.615 |
|
| 2022 |
Lu T, Ma R, Dong W, Teng KY, Kollath DS, Li Z, Yi J, Bustillos C, Ma S, Tian L, Mansour AG, Li Z, Settles EW, Zhang J, Keim PS, ... ... Yu J, et al. Off-the-shelf CAR natural killer cells secreting IL-15 target spike in treating COVID-19. Nature Communications. 13: 2576. PMID 35546150 DOI: 10.1038/s41467-022-30216-8 |
0.392 |
|
| 2022 |
Li Z, Ma R, Ma S, Tian L, Lu T, Zhang J, Mundy-Bosse BL, Zhang B, Marcucci G, Caligiuri MA, Yu J. ILC1s control leukemia stem cell fate and limit development of AML. Nature Immunology. PMID 35487987 DOI: 10.1038/s41590-022-01198-y |
0.314 |
|
| 2022 |
Ma S, Caligiuri MA, Yu J. A four-stage model for murine natural killer cell development in vivo. Journal of Hematology & Oncology. 15: 31. PMID 35313938 DOI: 10.1186/s13045-022-01243-1 |
0.357 |
|
| 2022 |
Li X, Ma S, Deng Y, Yi P, Yu J. Targeting the RNA mA modification for cancer immunotherapy. Molecular Cancer. 21: 76. PMID 35296338 DOI: 10.1186/s12943-022-01558-0 |
0.361 |
|
| 2022 |
Otani Y, Yoo JY, Lewis CT, Chao S, Swanner J, Shimizu T, Kang JM, Murphy SA, Rivera-Caraballo K, Hong B, Glorioso JC, Nakashima H, Lawler SE, Banasavadi-Siddegowda Y, Heiss JD, ... ... Yu J, et al. NOTCH induced MDSC recruitment after oHSV virotherapy in CNS cancer models modulates anti-tumor immunotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 35022322 DOI: 10.1158/1078-0432.CCR-21-2347 |
0.563 |
|
| 2021 |
Kumar A, Lee SJ, Liu Q, Chan AKN, Pokharel SP, Yu J, Chen CW, Swaminathan S. Generation and validation of CRISPR-engineered human natural killer cell lines for research and therapeutic applications. Star Protocols. 2: 100874. PMID 34746857 DOI: 10.1016/j.xpro.2021.100874 |
0.359 |
|
| 2021 |
Tian L, Xu B, Teng KY, Song M, Zhu Z, Chen Y, Wang J, Zhang J, Feng M, Kaur B, Rodriguez-Rodriguez L, Caligiuri MA, Yu J. Targeting Fc receptor-mediated effects and the "don't eat me" signal with an oncolytic virus expressing an anti-CD47 antibody to treat metastatic ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34645647 DOI: 10.1158/1078-0432.CCR-21-1248 |
0.537 |
|
| 2021 |
Xu B, Tian L, Chen J, Wang J, Ma R, Dong W, Li A, Zhang J, Antonio Chiocca E, Kaur B, Feng M, Caligiuri MA, Yu J. An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastoma. Nature Communications. 12: 5908. PMID 34625564 DOI: 10.1038/s41467-021-26003-6 |
0.577 |
|
| 2021 |
Lordo MR, Wu KG, Altynova E, Shilo N, Kronen P, Nalin AP, Weigel C, Zhang X, Yu J, Oakes CC, Caligiuri MA, Freud AG, Mundy-Bosse BL. Acute Myeloid Leukemia Alters Group 1 Innate Lymphoid Cell Differentiation from a Common Precursor. Journal of Immunology (Baltimore, Md. : 1950). PMID 34417259 DOI: 10.4049/jimmunol.2100023 |
0.321 |
|
| 2021 |
Wang Z, Ao X, Shen Z, Ao L, Wu X, Pu C, Guo W, Xing W, He M, Yuan H, Yu J, Li L, Xu X. TNF-α augments CXCL10/CXCR3 axis activity to induce Epithelial-Mesenchymal Transition in colon cancer cell. International Journal of Biological Sciences. 17: 2683-2702. PMID 34345201 DOI: 10.7150/ijbs.61350 |
0.301 |
|
| 2021 |
Lu T, Ma R, Li Z, Mansour AG, Teng KY, Chen L, Zhang J, Barr T, Caligiuri MA, Yu J. Hijacking TYRO3 from tumor cells via trogocytosis enhances NK-cell effector functions and proliferation. Cancer Immunology Research. PMID 34326137 DOI: 10.1158/2326-6066.CIR-20-1014 |
0.374 |
|
| 2021 |
Luo X, Xu J, Yu J, Yi P. Shaping Immune Responses in the Tumor Microenvironment of Ovarian Cancer. Frontiers in Immunology. 12: 692360. PMID 34248988 DOI: 10.3389/fimmu.2021.692360 |
0.355 |
|
| 2021 |
Ma S, Yan J, Barr T, Zhang J, Chen Z, Wang LS, Sun JC, Chen J, Caligiuri MA, Yu J. The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity. The Journal of Experimental Medicine. 218. PMID 34160549 DOI: 10.1084/jem.20210279 |
0.388 |
|
| 2021 |
Zhang M, Acklin S, Gillenwater J, Du W, Patra M, Yu H, Xu B, Yu J, Xia F. SIRT2 promotes murine melanoma progression through natural killer cell inhibition. Scientific Reports. 11: 12988. PMID 34155309 DOI: 10.1038/s41598-021-92445-z |
0.391 |
|
| 2021 |
Sun Y, Dong W, Tian L, Rao Y, Qin C, Jaramillo SA, Settles EW, Ma S, Zhang J, Yu K, Xu B, Yan J, Ma R, Li Z, Dadwal SS, ... ... Yu J, et al. Dual roles of a novel oncolytic viral vector-based SARS-CoV-2 vaccine: preventing COVID-19 and treating tumor progression. Biorxiv : the Preprint Server For Biology. PMID 34127971 DOI: 10.1101/2021.06.07.447286 |
0.376 |
|
| 2021 |
Duault C, Kumar A, Taghi Khani A, Lee SJ, Yang L, Huang M, Hurtz C, Manning B, Ghoda LY, McDonald T, Lacayo NJ, Sakamoto KM, Carroll MP, Tasian SK, Marcucci G, ... Yu J, et al. Activated Natural Killer Cells Predict Poor Clinical Prognosis in High-risk B- and T- cell Acute Lymphoblastic Leukemia. Blood. PMID 34077953 DOI: 10.1182/blood.2020009871 |
0.32 |
|
| 2021 |
Ma R, Lu T, Li Z, Teng KY, Mansour AG, Yu M, Tian L, Xu B, Ma S, Zhang J, Barr T, Peng Y, Caligiuri MA, Yu J. An oncolytic virus expressing IL-15/IL-15Rα combined with off-the-shelf EGFR-CAR NK cells targets glioblastoma. Cancer Research. PMID 34006525 DOI: 10.1158/0008-5472.CAN-21-0035 |
0.363 |
|
| 2021 |
Lordo MR, Scoville SD, Goel A, Yu J, Freud AG, Caligiuri MA, Mundy-Bosse BL. Unraveling the Role of Innate Lymphoid Cells in AcuteMyeloid Leukemia. Cancers. 13. PMID 33477248 DOI: 10.3390/cancers13020320 |
0.329 |
|
| 2020 |
Huang YW, Lin CW, Pan P, Shan T, Echeveste CE, Mo YY, Wang HT, Aldakkak M, Tsai S, Oshima K, Yearsley M, Xiao J, Cao H, Sun C, Du M, ... ... Yu J, et al. Black Raspberries Suppress Colorectal Cancer by Enhancing Smad4 Expression in Colonic Epithelium and Natural Killer Cells. Frontiers in Immunology. 11: 570683. PMID 33424832 DOI: 10.3389/fimmu.2020.570683 |
0.324 |
|
| 2020 |
Yilmaz A, Cui H, Caligiuri MA, Yu J. Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy. Journal of Hematology & Oncology. 13: 168. PMID 33287875 DOI: 10.1186/s13045-020-00998-9 |
0.408 |
|
| 2020 |
Pan P, Zhu Z, Oshima K, Aldakkak M, Tsai S, Huang YW, Dong W, Zhang J, Lin CW, Wang Y, Yearsley M, Yu J, Wang LS. Black raspberries suppress pancreatic cancer through modulation of NKp46, CD8, and CD11b immune cells. Food Frontiers. 1: 70-82. PMID 32368735 DOI: 10.1002/fft2.1 |
0.373 |
|
| 2020 |
Otani Y, Yoo JY, Chao S, Liu J, Jaime-Ramirez AC, Lee TJ, Hurwitz B, Yan Y, Dai H, Glorioso JC, Caligiuri MA, Yu J, Kaur B. Oncolytic HSV infected glioma cells activate NOTCH in adjacent tumor cells sensitizing tumors to gamma secretase inhibition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32139403 DOI: 10.1158/1078-0432.Ccr-19-3420 |
0.583 |
|
| 2019 |
Sette P, Amankulor N, Li A, Marzulli M, Leronni D, Zhang M, Goins WF, Kaur B, Bolyard C, Cripe TP, Yu J, Chiocca EA, Glorioso JC, Grandi P. GBM-Targeted oHSV Armed with Matrix Metalloproteinase 9 Enhances Anti-tumor Activity and Animal Survival. Molecular Therapy Oncolytics. 15: 214-222. PMID 31890868 DOI: 10.1016/J.Omto.2019.10.005 |
0.498 |
|
| 2019 |
Huang P, Wang F, Yang Y, Lai W, Meng M, Wu S, Peng H, Wang L, Zhan R, Imani S, Yu J, Chen B, Li X, Deng Y. Hematopoietic-Specific Deletion of Foxo1 Promotes NK Cell Specification and Proliferation. Frontiers in Immunology. 10: 1016. PMID 31139183 DOI: 10.3389/fimmu.2019.01016 |
0.332 |
|
| 2019 |
Yu J, Shi L, Shen X, Zhao Y. UCP2 regulates cholangiocarcinoma cell plasticity via mitochondria-to-AMPK signals. Biochemical Pharmacology. PMID 31085159 DOI: 10.1016/j.bcp.2019.05.017 |
0.331 |
|
| 2019 |
Pan P, Huang YW, Oshima K, Yearsley M, Zhang J, Arnold M, Yu J, Wang LS. The immunomodulatory potential of natural compounds in tumor-bearing mice and humans. Critical Reviews in Food Science and Nutrition. 1-16. PMID 30795687 DOI: 10.1080/10408398.2018.1537237 |
0.356 |
|
| 2019 |
Xu B, Ma R, Russell L, Yoo JY, Han J, Cui H, Yi P, Zhang J, Nakashima H, Dai H, Chiocca EA, Kaur B, Caligiuri MA, Yu J. Amendments: Publisher Correction: An oncolytic herpesvirus expressing E-cadherin improves survival in mouse models of glioblastoma. Nature Biotechnology. 37: 102. PMID 30605164 DOI: 10.1038/Nbt0119-102C |
0.417 |
|
| 2018 |
Russell L, Swanner J, Jaime-Ramirez AC, Wang Y, Sprague A, Banasavadi-Siddegowda Y, Yoo JY, Sizemore GM, Kladney R, Zhang J, Lehman NL, Ostrowski MC, Hong B, Caligiuri M, Yu J, et al. PTEN expression by an oncolytic herpesvirus directs T-cell mediated tumor clearance. Nature Communications. 9: 5006. PMID 30479334 DOI: 10.1038/S41467-018-07344-1 |
0.581 |
|
| 2018 |
Xu B, Ma R, Russell L, Yoo JY, Han J, Cui H, Yi P, Zhang J, Nakashima H, Dai H, Chiocca EA, Kaur B, Caligiuri MA, Yu J. An oncolytic herpesvirus expressing E-cadherin improves survival in mouse models of glioblastoma. Nature Biotechnology. PMID 30475349 DOI: 10.1038/Nbt.4302 |
0.589 |
|
| 2018 |
Wang F, Meng M, Mo B, Yang Y, Ji Y, Huang P, Lai W, Pan X, You T, Luo H, Guan X, Deng Y, Yuan S, Chu J, Namaka M, ... ... Yu J, et al. Crosstalks between mTORC1 and mTORC2 variagate cytokine signaling to control NK maturation and effector function. Nature Communications. 9: 4874. PMID 30451838 DOI: 10.1038/S41467-018-07277-9 |
0.303 |
|
| 2018 |
Wang Y, Chu J, Yi P, Dong W, Saultz JN, Wang Y, Wang H, Scoville SD, Zhang J, Wu LC, Deng Y, He X, Mundy-Bosse BL, Freud AG, Wang LS, ... ... Yu J, et al. SMAD4 promotes TGF-β-independent NK cell homeostasis and maturation and antitumor immunity. The Journal of Clinical Investigation. PMID 30183689 DOI: 10.1172/Jci121227 |
0.385 |
|
| 2018 |
Pan P, Huang YW, Oshima K, Yearsley M, Zhang J, Yu J, Arnold M, Wang LS. An immunological perspective for preventing cancer with berries. Journal of Berry Research. 8: 163-175. PMID 30159104 DOI: 10.3233/JBR-180305 |
0.348 |
|
| 2018 |
Scoville SD, Nalin AP, Chen L, Chen L, Zhang M, McConnell K, Beceiro Casas S, Ernst G, Traboulsi AA, Hashi N, Williams M, Zhang X, Hughes T, Mishra A, Benson DM, ... ... Yu J, et al. Human AML activates the AHR pathway to impair NK cell development and function. Blood. PMID 30158248 DOI: 10.1182/Blood-2018-03-838474 |
0.305 |
|
| 2018 |
Yi L, Chen L, Guo X, Lu T, Wang H, Ji X, Zhang J, Ren Y, Pan P, Kinghorn AD, Huang X, Wang LS, Fan Z, Caligiuri MA, Yu J. A Synthetic Disaccharide Derivative of Diphyllin, TAARD, Activates Human Natural Killer Cells to Secrete Interferon-Gamma Toll-Like Receptor-Mediated NF-κB and STAT3 Signaling Pathways. Frontiers in Immunology. 9: 1509. PMID 30072983 DOI: 10.3389/Fimmu.2018.01509 |
0.322 |
|
| 2018 |
Li X, Dong W, Nalin AP, Wang Y, Pan P, Xu B, Zhang Y, Tun S, Zhang J, Wang LS, He X, Caligiuri MA, Yu J. The natural product chitosan enhances the anti-tumor activity of natural killer cells by activating dendritic cells. Oncoimmunology. 7: e1431085. PMID 29872557 DOI: 10.1080/2162402X.2018.1431085 |
0.361 |
|
| 2018 |
Chan WK, Kang S, Youssef Y, Glankler EN, Barrett ER, Carter AM, Ahmed EH, Prasad A, Chen L, Zhang J, Benson DM, Caligiuri MA, Yu J. A CS1-NKG2D bispecific antibody collectively activates cytolytic immune cells against multiple myeloma. Cancer Immunology Research. PMID 29769244 DOI: 10.1158/2326-6066.Cir-17-0649 |
0.357 |
|
| 2018 |
Wang Y, Dong W, Zhang Y, Caligiuri MA, Yu J. Dependence of innate lymphoid cell 1 development on NKp46. Plos Biology. 16: e2004867. PMID 29702643 DOI: 10.1371/Journal.Pbio.2004867 |
0.391 |
|
| 2018 |
Kim Y, Yoo JY, Lee TJ, Liu J, Yu J, Caligiuri MA, Kaur B, Friedman A. Complex role of NK cells in regulation of oncolytic virus-bortezomib therapy. Proceedings of the National Academy of Sciences of the United States of America. PMID 29686060 DOI: 10.1073/Pnas.1715295115 |
0.621 |
|
| 2018 |
Wang Y, Zhang Y, Hughes T, Zhang J, Caligiuri MA, Benson DM, Yu J. Fratricide of NK Cells in Daratumumab Therapy for Multiple Myeloma Overcome by Ex Vivo Expanded Autologous NK Cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29666301 DOI: 10.1158/1078-0432.Ccr-17-3117 |
0.309 |
|
| 2018 |
Deng Y, Wang F, Hughes T, Yu J. FOXOs in Cancer Immunity: Knowns and Unknowns. Seminars in Cancer Biology. PMID 29309928 DOI: 10.1016/j.semcancer.2018.01.005 |
0.391 |
|
| 2017 |
Freud AG, Mundy-Bosse BL, Yu J, Caligiuri MA. The Broad Spectrum of Human Natural Killer Cell Diversity. Immunity. 47: 820-833. PMID 29166586 DOI: 10.1016/J.Immuni.2017.10.008 |
0.318 |
|
| 2017 |
Pan P, Kang S, Wang Y, Liu K, Oshima K, Huang YW, Zhang J, Yearsley M, Yu J, Wang LS. Black Raspberries Enhance Natural Killer Cell Infiltration into the Colon and Suppress the Progression of Colorectal Cancer. Frontiers in Immunology. 8: 997. PMID 28861089 DOI: 10.3389/fimmu.2017.00997 |
0.338 |
|
| 2017 |
Dai HS, Griffin N, Bolyard C, Mao HC, Zhang J, Cripe TP, Suenaga T, Arase H, Nakano I, Chiocca EA, Kaur B, Yu J, Caligiuri MA. The Fc Domain of Immunoglobulin Is Sufficient to Bridge NK Cells with Virally Infected Cells. Immunity. 47: 159-170.e10. PMID 28723548 DOI: 10.1016/J.Immuni.2017.06.019 |
0.542 |
|
| 2016 |
Bolyard CM, Meisen WH, Banasavadi-Siddegowda Y, Hardcastle J, Yoo JY, Wohleb ES, Wojton J, Yu JG, Dubin S, Khosla M, Xu B, Smith JG, Alvarez-Breckenridge C, Pow-Anpongkul P, Pichiorri F, ... ... Yu J, et al. BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection- implications for Oncolytic Viral Therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27852701 DOI: 10.1158/1078-0432.Ccr-16-1818 |
0.511 |
|
| 2016 |
Mundy-Bosse BL, Scoville SD, Chen L, McConnell K, Mao HC, Ahmed EH, Zorko N, Harvey S, Cole J, Zhang X, Costinean S, Croce CM, Larkin K, Byrd JC, Vasu S, ... ... Yu J, et al. MicroRNA-29b mediates altered innate immune development in acute leukemia. The Journal of Clinical Investigation. PMID 27775550 DOI: 10.1172/Jci85413 |
0.323 |
|
| 2016 |
Yoo JY, Jaime-Ramirez AC, Bolyard C, Dai H, Nallanagulagari T, Wojton J, Hurwitz B, Relation T, Yu JG, Lee TJ, Lotze MT, Zhang J, Croce CM, Yu J, Caligiuri MA, et al. Bortezomib treatment sensitizes oncolytic HSV-1 treated tumors to NK cell immunotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27390350 DOI: 10.1158/1078-0432.Ccr-16-1003 |
0.611 |
|
| 2016 |
Chen X, Han J, Chu J, Zhang L, Zhang J, Chen C, Chen L, Wang Y, Wang H, Yi L, Elder JB, Wang QE, He X, Kaur B, Chiocca EA, ... Yu J, et al. A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases. Oncotarget. PMID 27050072 DOI: 10.18632/Oncotarget.8526 |
0.58 |
|
| 2015 |
Han J, Chen X, Chu J, Xu B, Meisen WH, Chen L, Zhang L, Zhang J, He X, Wang QE, Chiocca EA, Kaur B, Caligiuri MA, Yu J. TGFβ Treatment Enhances Glioblastoma Virotherapy by Inhibiting the Innate Immune Response. Cancer Research. PMID 26631269 DOI: 10.1158/0008-5472.Can-15-0894 |
0.642 |
|
| 2015 |
Han J, Chu J, Keung Chan W, Zhang J, Wang Y, Cohen JB, Victor A, Meisen WH, Kim SH, Grandi P, Wang QE, He X, Nakano I, Chiocca EA, Glorioso Iii JC, ... ... Yu J, et al. CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells. Scientific Reports. 5: 11483. PMID 26155832 DOI: 10.1038/Srep11483 |
0.577 |
|
| 2015 |
Chen CP, Piao L, Chen X, Yu J, Masch R, Schatz F, Lockwood CJ, Huang SJ. Expression of Interferon γ by Decidual Cells and Natural Killer Cells at the Human Implantation Site: Implications for Preeclampsia, Spontaneous Abortion, and Intrauterine Growth Restriction. Reproductive Sciences (Thousand Oaks, Calif.). PMID 25963913 DOI: 10.1177/1933719115585148 |
0.308 |
|
| 2015 |
Meisen WH, Wohleb ES, Jaime-Ramirez AC, Bolyard C, Yoo JY, Russell L, Hardcastle J, Dubin S, Muili K, Yu J, Caligiuri M, Godbout J, Kaur B. The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor Microenvironment. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 3274-85. PMID 25829396 DOI: 10.1158/1078-0432.Ccr-14-3118 |
0.568 |
|
| 2015 |
Briercheck EL, Trotta R, Chen L, Hartlage AS, Cole JP, Cole TD, Mao C, Banerjee PP, Hsu HT, Mace EM, Ciarlariello D, Mundy-Bosse BL, Garcia-Cao I, Scoville SD, Yu L, ... ... Yu J, et al. PTEN is a negative regulator of NK cell cytolytic function. Journal of Immunology (Baltimore, Md. : 1950). 194: 1832-40. PMID 25595786 DOI: 10.4049/Jimmunol.1401224 |
0.345 |
|
| 2015 |
Xilin C, Han J, Jianhong C, Meisen W, Jianying Z, Chiocca EA, Kaur B, Caligiuri MA, Yu J. Modulation of Natural Killer Cell Activity in the Setting of Oncolytic Virotherapy and with a Chimeric Antigen Receptor Blood. 126: 210-210. DOI: 10.1182/Blood.V126.23.210.210 |
0.622 |
|
| 2014 |
Thorne AH, Meisen WH, Russell L, Yoo JY, Bolyard CM, Lathia JD, Rich J, Puduvalli VK, Mao H, Yu J, Caligiuri MA, Tridandapani S, Kaur B. Role of cysteine-rich 61 protein (CCN1) in macrophage-mediated oncolytic herpes simplex virus clearance. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 1678-87. PMID 24895995 DOI: 10.1038/Mt.2014.101 |
0.618 |
|
| 2014 |
Kim TH, Song J, Kim SH, Parikh AK, Mo X, Palanichamy K, Kaur B, Yu J, Yoon SO, Nakano I, Kwon CH. Piperlongumine treatment inactivates peroxiredoxin 4, exacerbates endoplasmic reticulum stress, and preferentially kills high-grade glioma cells. Neuro-Oncology. 16: 1354-64. PMID 24879047 DOI: 10.1093/Neuonc/Nou088 |
0.49 |
|
| 2014 |
Yoo JY, Hurwitz BS, Bolyard C, Yu JG, Zhang J, Selvendiran K, Rath KS, He S, Bailey Z, Eaves D, Cripe TP, Parris DS, Caligiuri MA, Yu J, Old M, et al. Bortezomib-induced unfolded protein response increases oncolytic HSV-1 replication resulting in synergistic antitumor effects. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 3787-98. PMID 24815720 DOI: 10.1158/1078-0432.Ccr-14-0553 |
0.509 |
|
| 2013 |
Collins SM, Bakan CE, Swartzel GD, Hofmeister CC, Efebera YA, Kwon H, Starling GC, Ciarlariello D, Bhaskar S, Briercheck EL, Hughes T, Yu J, Rice A, Benson DM. Elotuzumab directly enhances NK cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK cell function complementing ADCC. Cancer Immunology, Immunotherapy : Cii. 62: 1841-9. PMID 24162108 DOI: 10.1007/S00262-013-1493-8 |
0.351 |
|
| 2013 |
Yu J, Freud AG, Caligiuri MA. Location and cellular stages of natural killer cell development. Trends in Immunology. 34: 573-82. PMID 24055329 DOI: 10.1016/J.It.2013.07.005 |
0.325 |
|
| 2013 |
Alvarez-Breckenridge CA, Yu J, Caligiuri MA, Chiocca EA. Uncovering a novel mechanism whereby NK cells interfere with glioblastoma virotherapy. Oncoimmunology. 2: e23658. PMID 23734319 DOI: 10.4161/Onci.23658 |
0.368 |
|
| 2013 |
Yu J, Peng Y, Wu LC, Xie Z, Deng Y, Hughes T, He S, Mo X, Chiu M, Wang QE, He X, Liu S, Grever MR, Chan KK, Liu Z. Curcumin down-regulates DNA methyltransferase 1 and plays an anti-leukemic role in acute myeloid leukemia. Plos One. 8: e55934. PMID 23457487 DOI: 10.1371/journal.pone.0055934 |
0.311 |
|
| 2012 |
Ren Y, Wei M, Still PC, Yuan S, Deng Y, Chen X, Himmeldirk K, Kinghorn AD, Yu J. Synthesis and Antitumor Activity of Ellagic Acid Peracetate. Acs Medicinal Chemistry Letters. 3: 631-636. PMID 23185648 DOI: 10.1021/Ml300065Z |
0.314 |
|
| 2012 |
Alvarez-Breckenridge CA, Yu J, Price R, Wojton J, Pradarelli J, Mao H, Wei M, Wang Y, He S, Hardcastle J, Fernandez SA, Kaur B, Lawler SE, Vivier E, Mandelboim O, et al. NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors. Nature Medicine. 18: 1827-34. PMID 23178246 DOI: 10.1038/Nm.3013 |
0.611 |
|
| 2012 |
Alvarez-Breckenridge CA, Yu J, Price R, Wei M, Wang Y, Nowicki MO, Ha YP, Bergin S, Hwang C, Fernandez SA, Kaur B, Caligiuri MA, Chiocca EA. The histone deacetylase inhibitor valproic acid lessens NK cell action against oncolytic virus-infected glioblastoma cells by inhibition of STAT5/T-BET signaling and generation of gamma interferon. Journal of Virology. 86: 4566-77. PMID 22318143 DOI: 10.1128/Jvi.05545-11 |
0.624 |
|
| 2012 |
Alvarez-Breckenridge CA, Yu J, Kaur B, Caligiuri MA, Chiocca EA. Deciphering the Multifaceted Relationship between Oncolytic Viruses and Natural Killer Cells. Advances in Virology. 2012: 702839. PMID 22312364 DOI: 10.1155/2012/702839 |
0.597 |
|
| 2012 |
Haseley A, Boone S, Wojton J, Yu L, Yoo JY, Yu J, Kurozumi K, Glorioso JC, Caligiuri MA, Kaur B. Extracellular matrix protein CCN1 limits oncolytic efficacy in glioma. Cancer Research. 72: 1353-62. PMID 22282654 DOI: 10.1158/0008-5472.Can-11-2526 |
0.55 |
|
| 2012 |
Yu JH, Zhong XY, Zhang WG, Wang ZD, Dong Q, Tai S, Li H, Cui YF. CDK10 functions as a tumor suppressor gene and regulates survivability of biliary tract cancer cells. Oncology Reports. 27: 1266-76. PMID 22209942 DOI: 10.3892/or.2011.1617 |
0.307 |
|
| 2011 |
Trotta R, Ciarlariello D, Dal Col J, Mao H, Chen L, Briercheck E, Yu J, Zhang J, Perrotti D, Caligiuri MA. The PP2A inhibitor SET regulates granzyme B expression in human natural killer cells. Blood. 117: 2378-84. PMID 21156847 DOI: 10.1182/Blood-2010-05-285130 |
0.312 |
|
| 2009 |
Yu J, Ershler M, Yu L, Wei M, Hackanson B, Yokohama A, Mitsui T, Liu C, Mao H, Liu S, Liu Z, Trotta R, Liu CG, Liu X, Huang K, et al. TSC-22 contributes to hematopoietic precursor cell proliferation and repopulation and is epigenetically silenced in large granular lymphocyte leukemia. Blood. 113: 5558-67. PMID 19329776 DOI: 10.1182/Blood-2009-02-205732 |
0.348 |
|
| 2007 |
Trotta R, Ciarlariello D, Dal Col J, Allard J, Neviani P, Santhanam R, Mao H, Becknell B, Yu J, Ferketich AK, Thomas B, Modi A, Blaser BW, Perrotti D, Caligiuri MA. The PP2A inhibitor SET regulates natural killer cell IFN-gamma production. The Journal of Experimental Medicine. 204: 2397-405. PMID 17875674 DOI: 10.1084/Jem.20070419 |
0.326 |
|
| 2007 |
Becknell B, Hughes TL, Freud AG, Blaser BW, Yu J, Trotta R, Mao HC, Caligiuri de Jesús ML, Alghothani M, Benson DM, Lehman A, Jarjoura D, Perrotti D, Bates MD, Caligiuri MA. Hlx homeobox transcription factor negatively regulates interferon-gamma production in monokine-activated natural killer cells. Blood. 109: 2481-7. PMID 17110450 DOI: 10.1182/Blood-2006-10-050096 |
0.303 |
|
| 2006 |
Fulci G, Breymann L, Gianni D, Kurozomi K, Rhee SS, Yu J, Kaur B, Louis DN, Weissleder R, Caligiuri MA, Chiocca EA. Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses. Proceedings of the National Academy of Sciences of the United States of America. 103: 12873-8. PMID 16908838 DOI: 10.1073/Pnas.0605496103 |
0.57 |
|
| 2005 |
Trotta R, Parihar R, Yu J, Becknell B, Allard J, Wen J, Ding W, Mao H, Tridandapani S, Carson WE, Caligiuri MA. Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulation. Blood. 105: 3011-8. PMID 15604218 DOI: 10.1182/Blood-2004-10-4072 |
0.339 |
|
| 2004 |
Becknell B, Trotta R, Yu J, Ding W, Mao HC, Hughes T, Marburger T, Caligiuri MA. Efficient infection of human natural killer cells with an EBV/retroviral hybrid vector. Journal of Immunological Methods. 296: 115-23. PMID 15680156 DOI: 10.1016/J.Jim.2004.11.012 |
0.331 |
|
| Show low-probability matches. |